# K211722: Laser treatment system , models Nyx plus, Grace plus, Nemesis, Ares

- Pathway: 510(k) (Traditional)
- Applicant: Canadian Pioneer Medical Technology Corporation
- Decided: Feb 25, 2022 after 266 days
- Product code: GEX (Powered Laser Surgical Instrument)
- Device class: 2
- Regulation: 21 CFR 878.4810
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 24 generations back to K943450 (1995). 565 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 567 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K172193: Modified Alma Lasers Soprano XL™ Family ofMulti-Application & Multi-Technology Platforms [SopranoXL, SopranoXLi, SopranoICE and Soprano ICE Platinum] with Duo and Trio Diode Laser Modules., Soprano Duo and Trio Diode Laser Modules, Alma Lasers, Inc. (2018) Summary page 4.

## Most influential descendants
- K222915: Quadruple Laser System , Models : CPMT ARES , CPMT NEMESIS , CPMT NYX PLUS , CPMT GRACE PLUS (2022), 0 descendants of its own

## Indications for use
The Laser Treatment System, Models: Nyx Plus, Grace Plus, Ares, Nemesis, when used with the simultaneous triple wavelength module 755-808-1064 nm, is intended for : * Benign vascular lesions and vascular dependent lesions removal

Source page: https://510kreport.com/device/K211722
Methodology: https://510kreport.com/methodology